Masatake Miyoshi
Vice President, Client Relations
Masatake Miyoshi is Vice President of IMS Health operations in Japan. IMS is the world's leading provider of market intelligence to the pharmaceutical and healthcare industries serving more than 100 countries.
He is responsible for planning and implementing business and management strategies
toward securing IMS Japan’s continued middle- to long-term growth. He also directs
preparation and execution of communication strategies to boost the IMS Japan brand.
He joined IMS in April 2009. Prior to joining IMS, he was engaged in investigations and analyses of Japan’s pharmaceutical companies and industry from 1995
as a Managing Director and Senior Analyst (pharmaceuticals) at the leading U.S. investment bank affiliate Merrill Lynch Japan Securities.
Before joining Merrill Lynch, he was a securities analyst at the Wako Research
Institute, which was the research unit of Wako Securities (now Mizuho Securities). He
has been working as an analyst, mostly focusing on the pharmaceutical industry, for
over 20 years.
During his career in the securities industry, he was regularly ranked as one of Japan’s
top analysts, and presented diverse industry seminars and lectures. He also has close
ties to government. He served as a member of the Ministry of Health and Welfare (the
present Ministry of Health, Labor and Welfare) 1994 "Committee for the Future Outlook of the Pharmaceutical Industry", and an expert witness to the Ministry’s
2003 "Medical Device Industry Vision Roundtable".
His publications include "Pharmaceutical Product Market and Sales Forecast Know-how for R&D Investment 10 Years into the Future [in Japanese] (co-author)".
Miyoshi hold a B.A. from the Faculty of Law of Kyoto Sangyo University in March 1985.
